Hair transplant robot gets FDA nod

Published on April 26, 2011 at 10:56 PM · No Comments

By Dr Ananya Mandal, MD

The United States regulator, Food and Drugs Administrator (FDA) has approved a machine called the Artas System for commercial use. According to manufacturers Restoration Robotics, Artas is “an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting” by combining “several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface.” Artas can be used only on patients with straight brown or black hair at this stage.

The system uses its intelligence unit to harvest hair follicles with “image guided robotics” said the company. The system has a chair with a camera equipment that works under the doctor’s control. The hair follicles are manually transplanted after being extracted. The company says this system can improve extraction rates to 750 to 1,000 units per hour. This is much quicker and less invasive than traditional harvesting techniques they add.

artas_system_650x660

From the Manufacturer

What is the ARTAS™ System?

ARTAS is an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting. Through its design and ease-of-use, ARTAS has the potential to solve most of the technical challenges inherent in the manual FUE technique. The System is operated under the direction of a physician.

How Does the ARTAS™ System Work?

The ARTAS System combines several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface. After the System is positioned over the patient's donor area of the scalp, ARTAS is capable of identifying and harvesting follicular units. The follicular units are stored until they are implanted into the patient's recipient area using current manual techniques.

Posted in: Device / Technology News | Medical Procedure News

Tags: , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | हिन्दी | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals